Pharmaceutical Preparations Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Pharmaceutical Preparations
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2017-07-20
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$6.46+5,400186,872,3560%+$34,872
DM
2017-07-18
CORTCorcept Therapeutics IncMahoney David LDirS - Sale+OE$12.50-23,0061,135,673-2%-$287,597
ADM
2017-07-12
CORTCorcept Therapeutics IncMahoney David LDirS - Sale+OE$12.50-6,9941,135,673-1%-$87,448
D
2017-07-18
PTLAPortola Pharmaceuticals IncFu TaoEVP, CBOS - Sale+OE$65.00-5,8120-100%-$377,780
D
2017-07-18
PTLAPortola Pharmaceuticals IncCurnutte John TEVPS - Sale+OE$65.00-10,0000-100%-$650,000
2017-07-20
KALAKala Pharmaceuticals, Inc.Cdk Associates, L.L.C.10%P - Purchase$15.00+215,000215,000New+$3,225,000
D
2017-07-18
NKTRNektar TherapeuticsGergel Ivan P.SVP, Chief Medical OfficerS - Sale+OE$21.10-54,92043,572-56%-$1,158,812
2017-07-17
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.03+39,00021,708,8190%+$1,064
2017-07-17
IMMYImprimis Pharmaceuticals, Inc.Kammer Robert JDirS - Sale$3.05-10,0001,059,827-1%-$30,526
D
2017-07-17
VRTXVertex Pharmaceuticals Inc / MaChodakewitz JeffreyEVP GMDA, CMOS - Sale+OE$129.85-573122,5110%-$74,402
D
2017-07-17
PRTAProthena Corp PlcHenney Christopher SDirS - Sale+OE$66.13-5,0000-100%-$330,671
2017-07-17
CALACalithera Biosciences, Inc.Wong StephanieVP, FINANCE, SECRETARYS - Sale$18.41-3,55213,050-21%-$65,385
D
2017-07-17
PRTAProthena Corp PlcWalker Karin LSee RemarksS - Sale+OE$64.89-5,0000-100%-$324,439
2017-07-17
CALACalithera Biosciences, Inc.Orford KeithSVP, CLINICAL DEVELOPMENTS - Sale$18.31-2,1206,879-24%-$38,823
M
2017-07-14
NBRVNabriva Therapeutics PlcHbm Healthcare Investments (Cayman) Ltd.10%S - Sale$10.51-69,8542,442,153-3%-$734,264
2017-07-14
ICPTIntercept Pharmaceuticals IncKim Richard JSVP, Commercial USS - Sale$128.64-8911,253-1%-$11,449
D
2017-07-14
NKTRNektar TherapeuticsLingnau LutzDirS - Sale+OE$20.76-30,00023,450-56%-$622,800
2017-07-18
ALDRAlder Biopharmaceuticals IncYarno Wendy LDirP - Purchase$10.00+5,0005,000New+$50,000
2017-07-18
ALDRAlder Biopharmaceuticals IncDow Stephen MDirP - Purchase$10.00+25,000307,190+9%+$250,000
D
2017-07-17
IONSIonis Pharmaceuticals IncCrooke Stanley TCOB, CEOS - Sale+OE$52.45-16,500766,467-2%-$865,425
2017-07-17
JAZZJazz Pharmaceuticals PlcMiller Michael PatrickEVP, US CommercialS - Sale$154.97-20022,196-1%-$30,994
D
2017-07-14
CARACara Therapeutics, Inc.Chalmers Derek TPres, CEOS - Sale+OE$15.05-25,0001,082,292-2%-$376,250
2017-07-14
CARACara Therapeutics, Inc.Menzaghi Frederique Ph.D.VP-Research, DevelopmentS - Sale$15.00-3,000120,000-2%-$45,000
2017-07-17
FGENFibrogen IncKurkijarvi KaleviDirS - Sale$33.45-2,00032,000-6%-$66,900
2017-07-14
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.03+70021,669,8190%+$18
M
2017-07-13
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.03+98,77021,669,1190%+$2,626
D
2017-07-17
MKubota Pharmaceutical Holdings Co LtdScheibler LukasEVP of Research, DevelopmentS - Sale+OE$6.50-1,25011,108-10%-$8,125
2017-07-17
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$6.04+1,800186,866,9560%+$10,871
2017-07-17
CLVSClovis Oncology, Inc.Ivers-Read Gillian CSee RemarksS - Sale$91.56-3,000197,583-1%-$274,680
DM
2017-07-13
AIMTAimmune Therapeutics, Inc.Rozenman Mary M.See RemarksS - Sale+OE$21.44-14,940129-99%-$320,247
D
2017-07-13
BLCMBellicum Pharmaceuticals, IncMoseley KenSVP, GCS - Sale+OE$12.26-13,8231,126-92%-$169,470
2017-07-14
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$6.16+12,600186,865,1560%+$77,564
D
2017-07-03
PBYIPuma Biotechnology, Inc.Bryce Richard PaulSVP, CLINICAL RESEARCH, DEVS - Sale+OE$87.10-5,00029,237-15%-$435,500
M
2017-07-12
CORTCorcept Therapeutics IncMahoney David LDirS - Sale$12.50-6,9941,128,679-1%-$87,448
2017-07-12
KINKindred Biosciences, Inc.Park West Asset Management LLC10%P - Purchase$7.50+600,0005,156,791+13%+$4,500,000
D
2017-07-13
UTHRUnited Therapeutics CorpRothblatt Martine ACOB, CEOS - Sale+OE$130.44-1,238665,1440%-$161,486
2017-07-13
AMAGAmag Pharmaceuticals Inc.Krop JulieSVP Clinical, Regulatory, CMOS - Sale$20.00-4,93828,336-15%-$98,760
2017-07-12
SUPNSupernus Pharmaceuticals IncBhatt Padmanabh P.SVP of IP, CSOS - Sale$44.90-3,73521,209-15%-$167,702
M
2017-07-10
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.03+31,00021,570,3490%+$921
2017-07-13
FOLDAmicus Therapeutics IncPerceptive Advisors LLC10%P - Purchase$12.25+1,500,00017,888,597+9%+$18,375,000
M
2017-07-11
NBRVNabriva Therapeutics PlcHbm Healthcare Investments (Cayman) Ltd.10%S - Sale$10.53-57,1752,512,007-2%-$602,056
2017-07-11
ICPTIntercept Pharmaceuticals IncShapiro DavidCMO, EVP - DevelopmentS - Sale$124.01-55344,562-1%-$68,578
DM
2017-07-11
NKTRNektar TherapeuticsGergel Ivan P.SVP, Chief Medical OfficerS - Sale+OE$21.08-45,08043,572-51%-$950,318
DM
2017-07-11
CCXIChemocentryx, Inc.Bekker PetrusChief Medical OfficerS - Sale+OE$9.95-76,01359,839-56%-$756,070
2017-07-12
BGNEBeigene, Ltd.Wang XiaodongDirS - Sale$72.44-20,00012,739,9240%-$1,448,704
D
2017-07-11
PTLAPortola Pharmaceuticals IncDier MardiEVP, CFOS - Sale+OE$60.00-23,3500-100%-$1,401,000
2017-07-12
WVEWave Life Sciences Ltd.Panzara Michael A.Franchise Lead, NeurologyS - Sale$16.67-7,41415,336-33%-$123,620
2017-07-11
KDMNKadmon Holdings, Inc.Goldentree Asset Management LP10%S - Sale$3.69-34,4621,631,665-2%-$127,165
2017-07-12
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$6.12+3,600186,852,5560%+$22,050
2017-07-10
BGNEBeigene, Ltd.Glazer Donald W.DirS - Sale$72.15-10,8104,565,7940%-$779,900
M
2017-07-10
IMDZImmune Design Corp.Coleman Lewis WDirP - Purchase$9.05+12,00063,000+24%+$108,600
D
2017-07-10
PTGXProtagonist Therapeutics, IncLiu David YChief Scientific OfficerS - Sale+OE$12.68-3,5002,000-64%-$44,380
2017-07-10
BLCMBellicum Pharmaceuticals, IncSpencer David M.Chief Scientific OfficerS - Sale$11.54-10,000138,965-7%-$115,400
2017-07-11
ZFGNZafgen, Inc.Kim Dennis DChief Medical OfficerP - Purchase$3.39+10,00021,443+87%+$33,900
M
2017-07-11
AMARAmarillo Biosciences IncChen Stephen TPres, CEO, COB, 10%P - Purchase$0.29+4,0003,838,9570%+$1,150
2017-07-10
FGENFibrogen IncYu K PeonyChief Medical OfficerS - Sale$32.98-5,000216,507-2%-$164,900
2017-07-05
AKBAAkebia Therapeutics, Inc.Satter Muneer ADirP - Purchase$14.50+1,034,4823,037,042+52%+$14,999,989
D
2017-07-07
AGIOAgios Pharmaceuticals IncBiller ScottChief Scientific OfficerS - Sale+OE$55.00-2,14652,734-4%-$118,030
2017-07-07
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.03+10,00021,539,3490%+$292
2017-07-10
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$6.19+50,000186,848,9560%+$309,570
DM
2017-07-07
CCXIChemocentryx, Inc.Bekker PetrusChief Medical OfficerS - Sale+OE$9.30-19,87759,839-25%-$184,856
M
2017-07-06
IMDZImmune Design Corp.Coleman Lewis WDirP - Purchase$9.27+8,00051,000+19%+$74,150
2017-07-06
BGNEBeigene, Ltd.Oyler JohnCEO, 10%S - Sale$64.82-219,40069,185,5500%-$14,221,125
AD
2017-06-15
SELBSelecta Biosciences IncJohnston Lloyd P.COO, SVP, R, DS - Sale+OE$17.04-10,5121,606-87%-$179,141
M
2017-07-05
NBRVNabriva Therapeutics PlcHbm Healthcare Investments (Cayman) Ltd.10%S - Sale$10.52-2,6952,569,1820%-$28,357
M
2017-07-05
PAHCPhibro Animal Health CorpBfi Co., LLC10%S - Sale$36.49-32,00012,000-73%-$1,167,680
M
2017-07-05
PAHCPhibro Animal Health CorpBendheim JackPres, CEO, 10%S - Sale$36.49-32,00012,000-73%-$1,167,680
D
2017-07-05
ALRNAileron Therapeutics IncShanafelt ArmenDirP - Purchase$15.00+250,0001,094,987+30%+$3,750,000
D
2017-07-05
ALRNAileron Therapeutics IncLv Management Group, LLCFormer 10% ownerP - Purchase$15.00+250,0001,094,987+30%+$3,750,000
D
2017-07-05
ALRNAileron Therapeutics IncAju Ib Investment Co., Ltd.10%P - Purchase$15.00+24,929517,558+5%+$373,935
DM
2017-07-06
FGENFibrogen IncNeff Thomas BCEOS - Sale+OE$33.38-38,6363,528,700-1%-$1,289,547
2017-07-05
RIGLRigel Pharmaceuticals IncDuliege Anne-MarieChief Medical OfficerS - Sale$2.69-5,0000-100%-$13,427
D
2017-07-07
PRTAProthena Corp PlcSelkoe Dennis J.DirS - Sale+OE$58.11-3,5004,208-45%-$203,399
2017-07-07
CLSNCelsion CorpFritz Frederick J.DirP - Purchase$1.89+13,00016,341+389%+$24,570
2017-07-05
BPMCBlueprint Medicines CorpLynch DanielDirS - Sale$55.06-7,500211,842-3%-$412,950
D
2017-07-05
BPMCBlueprint Medicines CorpHaviland KateChief Business OfficerS - Sale+OE$54.66-7,2650-100%-$397,077
D
2017-07-06
FGENFibrogen IncCotroneo PatVP, Finance, CFOS - Sale+OE$34.00-4,000163,366-2%-$136,000
D
2017-07-06
UTHRUnited Therapeutics CorpRothblatt Martine ACOB, CEOS - Sale+OE$132.29-1,234664,2060%-$163,247
2017-07-06
CALACalithera Biosciences, Inc.Hecht CurtisSVP, BUS., CORP. DEVELOPMENTS - Sale$18.00-70015,940-4%-$12,600
2017-07-05
AMARAmarillo Biosciences IncChen Stephen TPres, CEO, COB, 10%P - Purchase$0.28+2,0003,834,9570%+$565
M
2017-07-03
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.03+28,00021,529,3490%+$855
2017-07-05
DOVADova Pharmaceuticals, Inc.Manning Paul BDir, 10%P - Purchase$17.00+150,00014,098,179+1%+$2,550,000
2017-07-05
DOVADova Pharmaceuticals, Inc.Allen Lee F Md PhdChief Medical OfficerP - Purchase$17.00+3,5003,500New+$59,500
2017-07-05
DOVADova Pharmaceuticals, Inc.Laliberte KevinSVP, Product DevelopmentP - Purchase$17.00+6,2006,200New+$105,400
2017-07-05
DOVADova Pharmaceuticals, Inc.Jeffs RogerDirP - Purchase$17.00+31,40031,400New+$533,800
2017-07-05
DOVADova Pharmaceuticals, Inc.Goldman Steven M.DirP - Purchase$17.94+72,00072,000New+$1,291,500
2017-07-05
DOVADova Pharmaceuticals, Inc.Sapir AlexPres, CEOP - Purchase$17.00+20,10020,100New+$341,700
2017-07-06
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$6.29+25,000186,798,9560%+$157,141
D
2017-07-03
ADROAduro Biotech, Inc.Lew JenniferSVP of FinanceS - Sale+OE$11.14-12,00042,595-22%-$133,632
DM
2017-07-03
ADROAduro Biotech, Inc.Isaacs Stephen TPres, CEOS - Sale+OE$11.06-40,000174,682-19%-$442,397
D
2017-07-03
ADROAduro Biotech, Inc.Brockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$11.02-10,00049,300-17%-$110,167
DM
2017-07-03
ADROAduro Biotech, Inc.Dubensky Thomas W.Chief Scientific OfficerS - Sale+OE$11.33-50,00039,900-56%-$566,638
D
2017-07-05
ALRNAileron Therapeutics IncGallagher Brian M. Jr.DirP - Purchase$15.00+273,3331,431,519+24%+$4,099,995
D
2017-07-05
ALRNAileron Therapeutics IncSigma Emerging Markets Ltd.10%P - Purchase$15.00+190,000423,086+82%+$2,850,000
D
2017-07-05
ALRNAileron Therapeutics IncExcel Medical Fund LP10%P - Purchase$15.00+60,0001,016,100+6%+$900,000
D
2017-07-05
ALRNAileron Therapeutics IncSatter Muneer A10%P - Purchase$15.00+33,333178,106+23%+$499,995
2017-07-05
KERXKeryx Biopharmaceuticals IncMadison GregPres, CEOS - Sale$7.67-910377,7680%-$6,980
2017-07-05
KERXKeryx Biopharmaceuticals IncAdams BrianGC, SecretaryS - Sale$7.67-641137,4950%-$4,916
2017-07-03
KINKindred Biosciences, Inc.Chin RichardPres, CEO, 10%S - Sale$8.26-13,0002,297,546-1%-$107,380
M
2017-07-03
EDGEEdge Therapeutics, Inc.Leuthner Brian APres, CEOS - Sale$10.19-7,500513,358-1%-$76,400

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top